Metabolite Testing in Drug Development
Authors:
- Angus N. R. NeddermanANAngus N. R. Nedderman
- Don K. WalkerDWDon K. Walker
- 13 January 2011
- book chapter
- Published by Springer Nature
- p. 131-143
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in manXenobiotica, 2008
- Metabolic Profiling of Endocrine-Disrupting Compounds by On-Line Cytochrome P450 Bioreaction Coupled to On-Line Receptor Affinity ScreeningChemical Research in Toxicology, 2007
- Metabolites and Safety: What Are the Concerns, and How Should We Address Them?Chemical Research in Toxicology, 2006
- In Vitro Metabolism of 2-Acetylbenzothiophene: Relevance to Zileuton HepatotoxicityChemical Research in Toxicology, 2004
- Accelerator mass spectrometry (AMS): recent experience of its use in a clinical study and the potential future of the techniqueXenobiotica, 2001
- Quantitative studies on the urinary metabolic fate of 2-chloro-4-trifluoromethylaniline in the rat using 19F-NMR spectroscopy and directly coupled HPLCNMR-MSXenobiotica, 1999
- Chemical and Immunochemical Comparison of Protein Adduct Formation of Four Carboxylate Drugs in Rat Liver and PlasmaChemical Research in Toxicology, 1996
- Application of Metabolism and Pharmacokinetic Studies to the Drug Discovery ProcessDrug Metabolism Reviews, 1996
- Human Plasma Protein Binding of the Angiotensin II Receptor Antagonist Losartan Potassium (DuP 753/MK 954) and Its Pharmacologically Active Metabolite EXP3174The Journal of Clinical Pharmacology, 1995
- Amiodarone pharmacokineticsAmerican Heart Journal, 1983